Benitec Biopharma Inc (BNTC)

08:02 AM

BenitecAnother Biopharma Rocket - Barchart

08:02 AM

Mar 12, 2025

Benitec Biopharma (NASDAQ:BNTC) Shares Cross Above 50-Day Moving Average – Here’s Why - Defense World

Mar 12, 2025

Mar 12, 2025

Benitec BiopharmaGetting To The Roots Of Oculopharyngeal Muscular Dystrophy - RTTNews

Mar 12, 2025

Mar 11, 2025

Benitec Biopharma stock soars to 52-week high of $13.32 By Investing.com - Investing.com Australia

Mar 11, 2025

Mar 11, 2025

Benitec Biopharma stock soars to 52-week high of $13.32 - Investing.com India

Mar 11, 2025

Mar 10, 2025

Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Mar 10, 2025

Mar 04, 2025

How to Take Advantage of moves in (BNTC) - Stock Traders Daily

Mar 04, 2025

Feb 27, 2025

Antisense & RNAi Therapeutics Market to Set Remarkable Growth - openPR

Feb 27, 2025

Feb 26, 2025

Benitec Biopharma to Participate in Upcoming Conferences in March - GlobeNewswire

Feb 26, 2025

Feb 26, 2025

Reviewing NexImmune (NASDAQ:NEXI) & Benitec Biopharma (NASDAQ:BNTC) - Defense World

Feb 26, 2025

Feb 25, 2025

Benitec Biopharma's SWOT analysis: gene therapy stock shows promise amid trials By Investing.com - Investing.com South Africa

Feb 25, 2025

Feb 25, 2025

Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise amid trials - Investing.com India

Feb 25, 2025

Feb 25, 2025

Benitec Biopharma's SWOT analysis: gene therapy stock shows promise amid trials - Investing.com

Feb 25, 2025

Feb 23, 2025

Wall Street Analysts Predict a 127.26% Upside in Benitec Biopharma (BNTC): Here's What You Should Know - MSN

Feb 23, 2025

Feb 23, 2025

HC Wainwright Reiterates “Buy” Rating for Benitec Biopharma (NASDAQ:BNTC) - Defense World

Feb 23, 2025

Feb 21, 2025

(BNTC) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Feb 21, 2025

Feb 21, 2025

H.C. Wainwright maintains $28 target on Benitec BioPharma stock By Investing.com - Investing.com UK

Feb 21, 2025

Feb 20, 2025

Benitec Biopharma (BNTC) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance

Feb 20, 2025

Feb 19, 2025

Citizens JMP maintains Benitec stock with $18 target By Investing.com - Investing.com Australia

Feb 19, 2025

Feb 19, 2025

Citizens JMP maintains Benitec stock with $18 target - Investing.com India

Feb 19, 2025

Feb 18, 2025

Benitec Biopharma (NASDAQ:BNTC) Announces Earnings Results, Beats Estimates By $0.19 EPS - MarketBeat

Feb 18, 2025

Feb 18, 2025

Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Rating of “Buy” from Analysts - Defense World

Feb 18, 2025

Feb 18, 2025

Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Feb 18, 2025

Feb 17, 2025

Benitec Biopharma (NASDAQ:BNTC) Stock Price Passes Below 50-Day Moving AverageHere's What Happened - MarketBeat

Feb 17, 2025

Feb 16, 2025

Benitec Biopharma Inc. Announces Q4 2024 Financial Results and Operational Update - Defense World

Feb 16, 2025

Feb 15, 2025

Benitec Biopharma Announces Acceptance of Late- Breaking - GlobeNewswire

Feb 15, 2025

Feb 14, 2025

Benitec presents new gene therapy data at MD conference By Investing.com - Investing.com Canada

Feb 14, 2025

Feb 14, 2025

Benitec presents new gene therapy data at MD conference - Investing.com India

Feb 14, 2025

Feb 14, 2025

Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update - TradingView

Feb 14, 2025

Feb 14, 2025

Benitec Biopharma Inc. Announces Late-Breaking Presentation on BB-301 Phase 1b/2a Clinical Study for Oculopharyngeal Muscular Dystrophy at 2025 MDA Conference - Nasdaq

Feb 14, 2025

Feb 14, 2025

Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference - The Manila Times

Feb 14, 2025

Feb 14, 2025

Benitec Biopharma Inc. (BNTC) reports earnings - Quartz

Feb 14, 2025

Feb 14, 2025

Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference - GlobeNewswire Inc.

Feb 14, 2025

Feb 14, 2025

Benitec Biopharma Inc. SEC 10-Q Report - TradingView

Feb 14, 2025

Feb 10, 2025

(BNTC) Investment Analysis - Stock Traders Daily

Feb 10, 2025

Feb 08, 2025

Benitec Biopharma (BNTC) Expected to Announce Quarterly Earnings on Monday - Defense World

Feb 08, 2025

Feb 06, 2025

Benitec Biopharma (BNTC) Projected to Post Earnings on Monday - MarketBeat

Feb 06, 2025

Feb 05, 2025

Institutional investors are Benitec Biopharma Inc.'s (NASDAQ:BNTC) biggest bettors and were rewarded after last week's US$33m market cap gain - Simply Wall St

Feb 05, 2025

Feb 04, 2025

Benitec Biopharma (NASDAQ:BNTC) Share Price Crosses Above Fifty Day Moving AverageHere's What Happened - MarketBeat

Feb 04, 2025

Jan 30, 2025

(BNTC) Technical Pivots with Risk Controls - Stock Traders Daily

Jan 30, 2025

Jan 27, 2025

Franklin Resources Inc. Acquires Significant Stake in Benitec Bi - GuruFocus.com

Jan 27, 2025

Jan 27, 2025

Benitec Biopharma to Participate in Upcoming Conferences in January and February - GlobeNewswire

Jan 27, 2025

Jan 27, 2025

BNTCBenitec Biopharma Inc. Latest Stock News & Market Updates - StockTitan

Jan 27, 2025

Jan 27, 2025

Benitec Biopharma Announces Three Major Conference Presentations for Early 2025 - StockTitan

Jan 27, 2025

Jan 26, 2025

Guggenheim Initiates Coverage of Benitec Biopharma (BNTC) with Buy Recommendation - MSN

Jan 26, 2025